Search

Your search keyword '"Tegazzin, V."' showing total 44 results

Search Constraints

Start Over You searched for: Author "Tegazzin, V." Remove constraint Author: "Tegazzin, V."
44 results on '"Tegazzin, V."'

Search Results

4. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects

5. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility

6. Undiagnosed myopathy before surgery and safe anaesthesia table

10. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility

11. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility

12. Recent advances in the diagnosis of malignant hyperthermia susceptibility: How confident can we be of genetic testing?

17. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families

18. Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release.

19. Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders

21. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families

22. An experimental model of myasthenia myopathy

23. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility

24. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.

25. Undiagnosed myopathy before surgery and safe anaesthesia table.

26. Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders.

27. A truncation in the RYR1 gene associated with central core lesions in skeletal muscle fibres.

28. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.

29. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.

30. Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.

31. Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia.

32. Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel.

33. Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.

35. [The role of intra- and extracellular Ca++ in coronary vessel contraction induced in vitro by noradrenaline following a beta-adrenergic block].

36. Vagal stimulation and exogenous acetylcholine in isolated rat stomach: calcitonin effect on contractile activity.

37. An experimental model of myasthenia myopathy.

38. Pathogenesis of late asthmatic reactions induced by exposure to isocyanates.

39. Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment.

40. Sciatic nerve block by the anterior and posterior approach for operations on the lower extremity. A comparative study.

41. [Changes in acetylcholine contractions induced by carnitine in coronary vessels isolated "in vitro"].

42. [Contractile response of segments of the coronary arteries to histamine and angiotensin II in the presence of anthocyanosides of myrtillus].

43. Caffeine sensitivity of sarcoplasmic reticulum of fast and slow fibers from normal and malignant hyperthermia human muscle.

44. [Possibilities of control of regulation of the function of arteriovenous anastomoses and of capillary blood flow by means of acupuncture].

Catalog

Books, media, physical & digital resources